Genetic analysis of specific and redundant roles for p38α and p38β MAPKs during mouse development

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 31, 2011, Pages 12764-12769

  Barrantes, Ivan Del Barco ^a,b   Coya, Juan Manuel ^a   Maina, Flavio ^c   Arthurd, J Simon C ^d   Nebreda, Angel R ^a,b,e  

^a Centro Nacional de Investigaciones Oncológicas   (Spain)

^b INSTITUTE FOR RESEARCH IN BIOMEDICINE   (Spain)

^c CNRS   (France)

^d UNIVERSITY OF DUNDEE   (United Kingdom)

^e INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

Author keywords

Embryonic development; Heart signaling

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE 11; MITOGEN ACTIVATED PROTEIN KINASE 14;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; EMBRYO DEVELOPMENT; GENE DELETION; GENE EXPRESSION; GENETIC ANALYSIS; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; CELL CYCLE; CELL PROLIFERATION; EMBRYO, MAMMALIAN; EMBRYONIC DEVELOPMENT; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HEART; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASE 11; MITOGEN-ACTIVATED PROTEIN KINASE 14; MYOCARDIUM; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TIME FACTORS;

ANIMALIA; MUS;

EID: 79961213639     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1015013108     Document Type: Article

References (41)

1. Cuadrado A, Nebreda AR (2010) Mechanisms and functions of p38 MAPK signalling. Biochem J 429:403-417.
2. Adams RH, et al. (2000) Essential role of p38alpha MAP kinase in placental but not embryonic cardiovascular development. Mol Cell 6:109-116.
3. Mudgett JS, et al. (2000) Essential role for p38alpha mitogen-activated protein kinase in placental angiogenesis. Proc Natl Acad Sci USA 97:10454-10459.
4. Hui L, et al. (2007) p38alpha suppresses normal and cancer cell proliferation by antagonizing the JNK-c-Jun pathway. Nat Genet 39:741-749.
5. Beardmore VA, et al. (2005) Generation and characterization of p38beta (MAPK11) gene-targeted mice. Mol Cell Biol 25:10454-10464.
6. Greenblatt MB, et al. (2010) The p38 MAPK pathway is essential for skeletogenesis and bone homeostasis in mice. J Clin Invest 120:2457-2473.
7. Zuzarte-Luís V, et al. (2004) A new role for BMP5 during limb development acting through the synergic activation of Smad and MAPK pathways. Dev Biol 272:39-52.
8. de Angelis L, et al. (2005) Regulation of vertebrate myotome development by the p38 MAP kinase-MEF2 signaling pathway. Dev Biol 283:171-179.
9. Zohn IE, et al. (2006) p38 and a p38-interacting protein are critical for downregulation of E-cadherin during mouse gastrulation. Cell 125:957-969.
10. Godl K, et al. (2003) An efficient proteomics method to identify the cellular targets of protein kinase inhibitors. Proc Natl Acad Sci USA 100:15434-15439.
11. Engel FB, et al. (2005) p38 MAP kinase inhibition enables proliferation of adult mammalian cardiomyocytes. Genes Dev 19:1175-1187.
12. Buckingham M, Meilhac S, Zaffran S (2005) Building the mammalian heart from two sources of myocardial cells. Nat Rev Genet 6:826-835.
13. Peterkin T, Gibson A, Loose M, Patient R (2005) The roles of GATA-4, -5 and -6 in vertebrate heart development. Semin Cell Dev Biol 16:83-94.
14. Dunwoodie SL (2007) Combinatorial signaling in the heart orchestrates cardiac induction, lineage specification and chamber formation. Semin Cell Dev Biol 18:54-66.
15. Charron F, et al. (2001) Tissue-specific GATA factors are transcriptional effectors of the small GTPase RhoA. Genes Dev 15:2702-2719.
16. Han J, Molkentin JD (2000) Regulation of MEF2 by p38 MAPK and its implication in cardiomyocyte biology. Trends Cardiovasc Med 10:19-22.
17. Holler KL, et al. (2010) Targeted deletion of Hand2 in cardiac neural crest-derived cells influences cardiac gene expressionand outflowtract development. Dev Biol 341:291-304.
18. Tsuchihashi T, et al. (2011) Hand2 function in second heart field progenitors is essential for cardiogenesis. Dev Biol 351:62-69.
19. Wang Y, et al. (1998) Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 mitogen-activated protein kinase family. J Biol Chem 273:2161-2168.
20. Zhang S, et al. (2003) The role of the Grb2-p38 MAPK signaling pathway in cardiac hypertrophy and fibrosis. J Clin Invest 111:833-841.
21. Liu N, Olson EN (2010) MicroRNA regulatory networks in cardiovascular development. Dev Cell 18:510-525.
22. Liu N, et al. (2007) An intragenic MEF2-dependent enhancer directs muscle-specific expression of microRNAs 1 and 133. Proc Natl Acad Sci USA 104:20844-20849.
23. Carè A, et al. (2007) MicroRNA-133 controls cardiac hypertrophy. Nat Med 13:613-618.
24. Zhao Y, et al. (2007) Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. Cell 129:303-317.
25. Liu N, et al. (2008) microRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart. Genes Dev 22:3242-3254.
26. Pasumarthi KB, Field LJ (2002) Cardiomyocyte cell cycle regulation. Circ Res 90:1044-1054.
27. Chaudhry HW, et al. (2004) Cyclin A2 mediates cardiomyocyte mitosis in the post-mitotic myocardium. J Biol Chem 279:35858-35866.
28. Cheng RK, et al. (2007) Cyclin A2 induces cardiac regeneration after myocardial infarction and prevents heart failure. Circ Res 100:1741-1748.
29. Kozar K, et al. (2004) Mouse development and cell proliferation in the absence of D-cyclins. Cell 118:477-491.
30. Martin-Puig S, Wang Z, Chien KR (2008) Lives of a heart cell: Tracing the origins of cardiac progenitors. Cell Stem Cell 2:320-331.
31. Hoffman JI, Kaplan S, Liberthson RR (2004) Prevalence of congenital heart disease. Am Heart J 147:425-439.
32. Potthoff MJ, Olson EN (2007) MEF2: A central regulator of diverse developmental programs. Development 134:4131-4140.
33. Lin Q, Schwarz J, Bucana C, Olson EN (1997) Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C. Science 276:1404-1407.
34. Vong LH, Ragusa MJ, Schwarz JJ (2005) Generation of conditional Mef2cloxP/loxP mice for temporal- and tissue-specific analyses. Genesis 43:43-48.
35. Naya FJ, et al. (2002) Mitochondrial deficiency and cardiac sudden death in mice lacking the MEF2A transcription factor. Nat Med 8:1303-1309.
36. Xin M, et al. (2006) A threshold of GATA4 and GATA6 expression is required for cardiovascular development. Proc Natl Acad Sci USA 103:11189-11194.
37. Lynch J, et al. (2005) Calreticulin signals upstream of calcineurin and MEF2C in a critical Ca(2+)-dependent signaling cascade. J Cell Biol 170:37-47.
38. Heinrichsdorff J, Luedde T, Perdiguero E, Nebreda AR, Pasparakis M (2008) p38 alpha MAPK inhibits JNK activation and collaborates with IkappaB kinase 2 to prevent endotoxin-induced liver failure. EMBO Rep 9:1048-1054.
39. Ventura JJ, et al. (2007) p38alpha MAP kinase is essential in lung stem and progenitor cell proliferation and differentiation. Nat Genet 39:750-758.
40. Hayashi S, Lewis P, Pevny L, McMahon AP (2002) Efficient gene modulation in mouse epiblast using a Sox2Cre transgenic mouse strain. Mech Dev 119(Suppl 1):S97-S101.
41. Hogan B, Beddington R, Costantini F, Lacy E, eds (1994) Manipulating the Mouse Embryo. A Laboratory Manual. (Cold Spring Harbor Lab Press, Cold Spring Harbor, NY).